News
-
-
-
COMMUNIQUÉ DE PRESSE
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th
Aspire Biopharma to attend Sidoti Micro-Cap Virtual Investor Conference on August 19-20, 2026. Management to discuss clinical pipeline and recent acquisition of Dura Driver Control Systems -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)
Aspire Biopharma Holdings, Inc. submits Pre-IND meeting request to FDA for fast-acting sublingual aspirin formulation to treat acute myocardial infarction, demonstrating rapid action and potential for FDA approval -
